LEXARIA BIOSCIENCE CORP. Current Assets
LEXARIA BIOSCIENCE CORP. (LEXX) had Current Assets of $4.06 million as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-13
- 2026-05-31: Assets, Current $4.06M.
- 2026-02-28: Assets, Current $5.77M.
- 2025-11-30: Assets, Current $5.36M.
- 2025-08-31: Assets, Current $3.47M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-05-31 | $4.06M 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $5.77M 10-Q · filed 2026-04-13 | |
| 2025-11-30 | $5.36M 10-Q · filed 2026-01-13 | |
| 2025-08-31 | $3.47M 10-Q · filed 2026-07-13 | |
| 2025-05-31 | $5.81M 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $7.72M 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $8.83M 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $7.90M 10-K · filed 2025-11-28 | |
| 2024-05-31 | $9.09M 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $5.42M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $2.69M 10-Q · filed 2024-01-12 | |
| 2023-08-31 | $2.15M 10-K · filed 2024-11-26 | $2.20M 10-K · filed 2023-11-20 |
| 2023-05-31 | $4.24M 10-Q · filed 2023-07-14 | |
| 2023-02-28 | $4.00M 10-Q · filed 2023-04-14 | |
| 2022-11-30 | $5.36M 10-Q/A · filed 2023-01-18 | |
| 2022-08-31 | $6.98M 10-K · filed 2023-11-20 | |
| 2022-05-31 | $8.29M 10-Q · filed 2022-07-14 | |
| 2022-02-28 | $10.57M 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $10.90M 10-Q · filed 2022-01-14 | |
| 2021-08-31 | $12.44M 10-K · filed 2022-11-28 | |
| 2021-05-31 | $9.69M 10-Q · filed 2021-07-15 | |
| 2021-02-28 | $10.95M 10-Q · filed 2021-04-14 | |
| 2020-11-30 | $1.31M 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $1.93M 10-K · filed 2021-11-29 | |
| 2020-05-31 | $2.53M 10-Q · filed 2020-06-29 | |
| 2020-02-29 | $1.18M 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $1.91M 10-Q · filed 2020-01-09 | |
| 2019-08-31 | $1.82M 10-K · filed 2020-10-15 | |
| 2019-05-31 | $2.61M 10-Q · filed 2019-07-08 | |
| 2019-02-28 | $3.64M 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $3.23M 10-Q · filed 2019-01-11 | |
| 2018-08-31 | $2.28M 10-K · filed 2019-11-14 | |
| 2018-05-31 | $2.59M 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $2.75M 10-Q · filed 2018-04-12 | |
| 2017-11-30 | $2.42M 10-Q · filed 2018-01-12 | |
| 2017-08-31 | $2.80M 10-K · filed 2018-11-14 | |
| 2017-05-31 | $3.08M 10-Q · filed 2017-07-14 | |
| 2017-02-28 | $803.69K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $1.07M 10-Q · filed 2017-01-13 | |
| 2016-08-31 | $510.17K 10-K · filed 2017-11-27 | |
| 2016-05-31 | $279.36K 10-Q · filed 2016-07-13 | |
| 2016-02-29 | $337.39K 10-Q · filed 2016-04-13 | |
| 2015-11-30 | $456.19K 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $674.73K 10-K · filed 2016-11-29 | |
| 2015-05-31 | $1.16M 10-Q · filed 2015-07-14 | |
| 2015-02-28 | $1.16M 10-Q · filed 2015-04-14 | |
| 2014-11-30 | $2.20M 10-Q · filed 2015-01-14 | |
| 2014-08-31 | $2.57M 10-K · filed 2015-11-27 | |
| 2014-07-31 | $1.20M 10-Q · filed 2014-11-14 | |
| 2014-04-30 | $1.47M 10-Q · filed 2014-06-12 | |
| 2014-01-31 | $164.65K 10-Q · filed 2014-03-12 | |
| 2013-10-31 | $146.27K 10-KT · filed 2014-12-09 | |
| 2013-07-31 | $182.33K 10-Q · filed 2013-09-10 | |
| 2013-04-30 | $216.21K 10-Q · filed 2013-06-12 | |
| 2013-01-31 | $284.78K 10-Q · filed 2013-03-13 | |
| 2012-10-31 | $472.93K 10-K · filed 2014-01-24 | |
| 2012-07-31 | $517.26K 10-Q · filed 2012-09-12 | |
| 2012-04-30 | $264.50K 10-Q · filed 2012-06-07 | |
| 2012-01-31 | $322.82K 10-Q · filed 2012-03-13 | |
| 2011-10-31 | $264.23K 10-K · filed 2013-01-29 | |
| 2011-07-31 | $730.32K 10-Q · filed 2011-09-14 | |
| 2010-10-31 | $140.21K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |